Study | Exclusion reasons | Remarks | Reference(s) | ||
---|---|---|---|---|---|
Million, 2020 | single-arm | no control group |
Million Travel Med Infect Dis 2020; :101738 10.1016/j.tmaid.2020.101738 |
||
Guerin, 2020 | non randomized controlled trial | other | no binary endpoints |
Guérin, Preprints 2020, 2020050486 (doi: 10.20944/preprints202005.0486.v1). |
|
Alberici, 2020 | retrospective cohort | other | HCQ efficacy or safety evaluation wasn't a prespecified endpoint |
Alberici F Kidney Int 2020 Jul;98(1):20-26. 10.1016/j.kint.2020.04.030 |